New blood pressure drug shows promise in early human test
Disease control
Completed
This early-stage study tested a single dose of a new drug called SGB-3908 in 40 healthy adults and people with mild high blood pressure. The main goal was to check safety and how the drug moves through the body. Researchers also looked at how it affects blood pressure-related mar…
Phase: PHASE1 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC